{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:10:51Z","timestamp":1794276651818,"version":"4.9.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In 2017, Liberia became one of the first countries in the African region to develop and implement a national strategy for integrated case management of Neglected Tropical Diseases (CM-NTDs), specifically Buruli ulcer, leprosy, lymphatic filariasis morbidities, and yaws. Implementing this plan moves the NTD program from many countries' fragmented (vertical) disease management. This study explores to what extent an integrated approach offers a cost-effective investment for national health systems.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study is a mixed-method economic evaluation that explores the cost-effectiveness of the integrated CM-NTDs approach compared to the fragmented (vertical) disease management. Primary data were collected from two integrated intervention counties and two non-intervention counties to determine the relative cost-effectiveness of the integrated program model vs. fragmented (vertical) care. Data was sourced from the NTDs program annual budgets and financial reports for integrated CM-NTDs and Mass Drug Administration (MDA) to determine cost drivers and effectiveness.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The total cost incurred by the integrated CM-NTD approach from 2017 to 2019 was US$ 789,856.30, with the highest percentage of costs for program staffing and motivation (41.8%), followed by operating costs (24.8%). In the two counties implementing fragmented (vertical) disease management, approximately US$ 325,000 was spent on the diagnosis of 84 persons and the treatment of twenty-four persons suffering from NTDs. While 2.5 times as much was spent in integrated counties, 9\u201310 times more patients were diagnosed and treated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The cost of a patient being diagnosed under the fragmented (vertical) implementation is five times higher than integrated CM-NTDs, and providing treatment is ten times as costly. Findings indicate that the integrated CM-NTDs strategy has achieved its primary objective of improved access to NTD services. The success of implementing an integrated CM-NTDs approach in Liberia, presented in this paper, demonstrates that NTD integration is a cost-minimizing solution.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12913-023-09685-0","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T04:01:43Z","timestamp":1688011303000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Assessing the cost-effectiveness of integrated case management of Neglected Tropical Diseases in Liberia"],"prefix":"10.1186","volume":"23","author":[{"given":"Tiawanlyn G.","family":"Godwin-Akpan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Diaconu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Edmiston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"John Solunta","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Sosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Weiland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsor K.","family":"Kollie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"issue":"5","key":"9685_CR1","first-page":"e0009373","volume":"15","author":"A Casulli","year":"2021","unstructured":"Casulli A. New global targets for NTDs in the WHO roadmap 2021\u20132030. Plos NTDs. 2021;15(5):e0009373.","journal-title":"Plos NTDs"},{"issue":"suppl 1","key":"9685_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/inthealth\/ihw001","volume":"8","author":"LF Mieras","year":"2016","unstructured":"Mieras LF, Anand S, van Brakel WH, Hamilton HC, Martin Kollmann KH, Mackenzie C, et al. Neglected tropical diseases, cross-cutting issues workshop, 4\u20136 February 2015, Utrecht, the Netherlands: meeting report. Int Health. 2016;8(suppl 1):7\u201311.","journal-title":"Int Health"},{"key":"9685_CR3","volume-title":"Accelerating work to overcome the global impact of neglected tropical diseases: a roadmap for implementation","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. Accelerating work to overcome the global impact of neglected tropical diseases: a roadmap for implementation. 2012."},{"issue":"4","key":"9685_CR4","doi-asserted-by":"publisher","first-page":"e0004521","DOI":"10.1371\/journal.pntd.0004521","volume":"10","author":"M Rosenberg","year":"2016","unstructured":"Rosenberg M, Utzinger J, Addiss DG. Preventive chemotherapy versus innovative and intensified disease management in neglected tropical diseases: a distinction whose shelf life has expired. PLoS Negl Trop Dis. 2016;10(4):e0004521.","journal-title":"PLoS Negl Trop Dis"},{"key":"9685_CR5","unstructured":"Ministry of Health, Liberia. Strategic Plan for Integrated Case Management of Neglected Tropical Diseases (NTDs) 2016-2020. 2016."},{"key":"9685_CR6","volume-title":"Continuity and coordination of care: a practice brief to support implementation of the WHO framework on integrated people-centred health services","author":"World Health Organizagtion","year":"2018","unstructured":"World Health Organizagtion. Continuity and coordination of care: a practice brief to support implementation of the WHO framework on integrated people-centred health services. 2018."},{"issue":"1","key":"9685_CR7","doi-asserted-by":"publisher","first-page":"e0005136","DOI":"10.1371\/journal.pntd.0005136","volume":"11","author":"O Mitj\u00e0","year":"2017","unstructured":"Mitj\u00e0 O, Marks M, Bertran L, Kollie K, Argaw D, Fahal AH, et al. Integrated control and management of neglected tropical skin diseases. PLoS Negl Trop Dis. 2017;11(1):e0005136.","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"9685_CR8","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/trstmh\/trx008","volume":"110","author":"R Hay","year":"2016","unstructured":"Hay R. Skin NTDs: an opportunity for integrated care. Trans R Soc Trop Med Hyg. 2016;110(12):679\u201380.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"10","key":"9685_CR9","doi-asserted-by":"publisher","first-page":"e0005085","DOI":"10.1371\/journal.pntd.0005085","volume":"10","author":"AR Means","year":"2016","unstructured":"Means AR, Jacobson J, Mosher AW, Walson JL. Integrated healthcare delivery: a qualitative research approach to identifying and harmonizing perspectives of integrated neglected tropical disease programs. PLoS Negl Trop Dis. 2016;10(10):e0005085.","journal-title":"PLoS Negl Trop Dis"},{"key":"9685_CR10","unstructured":"Wilkinson T, Chalkidou K, Walker D. Bill and Melinda Gates Foundation Methods for Economic Evaluation Project (MEEP). Lopert R, editor. NICE International; 2014 [cited 2022 Mar 24]. Available from: https:\/\/www.idsihealth.org\/wp-content\/uploads\/2015\/01\/MEEP-report.pdf."},{"key":"9685_CR11","volume-title":"On discount rates for economic evaluations in global health. Health Policy Plan","author":"M Haacker","year":"2019","unstructured":"Haacker M, Hallett TB, Atun R. On discount rates for economic evaluations in global health. Health Policy Plan. 2019."},{"issue":"1","key":"9685_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13033-015-0004-z","volume":"9","author":"DL Marais","year":"2015","unstructured":"Marais DL, Petersen I. Health system governance to support integrated mental health care in South Africa: challenges and opportunities. Int J Ment Health Syst. 2015;9(1):14.","journal-title":"Int J Ment Health Syst"},{"issue":"7","key":"9685_CR13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.pt.2006.05.007","volume":"22","author":"MA Brady","year":"2006","unstructured":"Brady MA, Hooper PJ, Ottesen EA. Projected benefits from integrating NTD programs in sub-Saharan Africa. Trends Parasitol. 2006;22(7):285\u201391.","journal-title":"Trends Parasitol"},{"issue":"1","key":"9685_CR14","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1186\/s12889-020-08632-6","volume":"20","author":"AP Koffi","year":"2020","unstructured":"Koffi AP, Yao TAK, Barogui YT, Diez G, Djakeaux S, Zahiri MH, et al. Integrated approach in the control and management of skin neglected tropical diseases in three health districts of C\u00f4te d\u2019Ivoire. BMC Public Health. 2020;20(1):517.","journal-title":"BMC Public Health"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-023-09685-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-023-09685-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-023-09685-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T04:01:49Z","timestamp":1688011309000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-023-09685-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["9685"],"URL":"https:\/\/doi.org\/10.1186\/s12913-023-09685-0","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,29]]},"assertion":[{"value":"20 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board (IRB) obtained ethical approval from the University of Liberia Pacific Institute for Research and Evaluation (UL-PIRE). The Institutional Review Board (IRB) reviewed the methodology, including the key informant interview toolkit, and approved to conduct of the study from June 1, 2020, to September 30, 2020. The evaluation proposal was also shared with the NTDs Program for approval to access program data. All procedures were conducted in accordance with the Declaration of Helsinki. Informed consent was obtained from each participant in the assessment before each FGD, KIIs, and reflexive session. The consent form was read, and all participants had an opportunity to ask questions about the study and the implications of their participation. Participants' confidentiality and the right to withdraw from the research at any time during the interview were assured.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"705"}}